EyePoint Pharmaceuticals Statistics
Total Valuation
EYPT has a market cap or net worth of $558.75 million. The enterprise value is $264.64 million.
Important Dates
The last earnings date was Wednesday, May 7, 2025, before market open.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EYPT has 68.81 million shares outstanding. The number of shares has increased by 41.51% in one year.
| Current Share Class | 68.81M |
| Shares Outstanding | 68.81M |
| Shares Change (YoY) | +41.51% |
| Shares Change (QoQ) | +8.07% |
| Owned by Insiders (%) | 0.99% |
| Owned by Institutions (%) | 71.66% |
| Float | 43.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.77 |
| Forward PS | 43.06 |
| PB Ratio | 1.87 |
| P/TBV Ratio | 1.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.85, with a Debt / Equity ratio of 0.08.
| Current Ratio | 7.85 |
| Quick Ratio | 7.65 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11,526.43 |
Financial Efficiency
Return on equity (ROE) is -53.54% and return on invested capital (ROIC) is -34.89%.
| Return on Equity (ROE) | -53.54% |
| Return on Assets (ROA) | -29.16% |
| Return on Invested Capital (ROIC) | -34.89% |
| Return on Capital Employed (ROCE) | -50.29% |
| Revenue Per Employee | $339,648 |
| Profits Per Employee | -$889,582 |
| Employee Count | 165 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 50.64 |
Taxes
In the past 12 months, EYPT has paid $90,000 in taxes.
| Income Tax | 90,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.18% in the last 52 weeks. The beta is 1.60, so EYPT's price volatility has been higher than the market average.
| Beta (5Y) | 1.60 |
| 52-Week Price Change | -24.18% |
| 50-Day Moving Average | 6.03 |
| 200-Day Moving Average | 7.77 |
| Relative Strength Index (RSI) | 71.90 |
| Average Volume (20 Days) | 926,233 |
Short Selling Information
The latest short interest is 7.21 million, so 10.47% of the outstanding shares have been sold short.
| Short Interest | 7.21M |
| Short Previous Month | 10.07M |
| Short % of Shares Out | 10.47% |
| Short % of Float | 16.71% |
| Short Ratio (days to cover) | 11.39 |
Income Statement
In the last 12 months, EYPT had revenue of $56.04 million and -$146.78 million in losses. Loss per share was -$2.43.
| Revenue | 56.04M |
| Gross Profit | -105.66M |
| Operating Income | -161.37M |
| Pretax Income | -86.74M |
| Net Income | -146.78M |
| EBITDA | -159.64M |
| EBIT | -161.37M |
| Loss Per Share | -$2.43 |
Full Income StatementBalance Sheet
The company has $318.19 million in cash and $24.08 million in debt, giving a net cash position of $294.11 million or $4.27 per share.
| Cash & Cash Equivalents | 318.19M |
| Total Debt | 24.08M |
| Net Cash | 294.11M |
| Net Cash Per Share | $4.27 |
| Equity (Book Value) | 298.40M |
| Book Value Per Share | 4.34 |
| Working Capital | 285.31M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$148.18 million and capital expenditures -$3.13 million, giving a free cash flow of -$151.31 million.
| Operating Cash Flow | -148.18M |
| Capital Expenditures | -3.13M |
| Free Cash Flow | -151.31M |
| FCF Per Share | -$2.20 |
Full Cash Flow StatementMargins
Gross margin is -188.54%, with operating and profit margins of -287.94% and -261.91%.
| Gross Margin | -188.54% |
| Operating Margin | -287.94% |
| Pretax Margin | -261.75% |
| Profit Margin | -261.91% |
| EBITDA Margin | -284.85% |
| EBIT Margin | -287.94% |
| FCF Margin | n/a |
Dividends & Yields
EYPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -41.51% |
| Shareholder Yield | -41.51% |
| Earnings Yield | -26.27% |
| FCF Yield | -27.08% |
Analyst Forecast
The average price target for EYPT is $24.29, which is 199.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24.29 |
| Price Target Difference | 199.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 66.30% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on December 9, 2020. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Dec 9, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
EYPT has an Altman Z-Score of 1.38 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.38 |
| Piotroski F-Score | 1 |